Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Assessment of right ventricular responses to therapy in pulmonary hypertension.

Spruijt OA, Bogaard HJ, Vonk-Noordegraaf A.

Drug Discov Today. 2014 Aug;19(8):1246-50. doi: 10.1016/j.drudis.2014.03.008. Epub 2014 Mar 15. Review.

PMID:
24637045
2.

Current therapeutics and practical management strategies for pulmonary arterial hypertension.

Agarwal R, Gomberg-Maitland M.

Am Heart J. 2011 Aug;162(2):201-13. doi: 10.1016/j.ahj.2011.05.012. Epub 2011 Jul 13. Review.

PMID:
21835279
3.

Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review.

Price LC, Wort SJ, Finney SJ, Marino PS, Brett SJ.

Crit Care. 2010;14(5):R169. doi: 10.1186/cc9264. Epub 2010 Sep 21. Review.

4.

Right ventricular adaptation to pulmonary hypertension: an interspecies comparison.

Wauthy P, Pagnamenta A, Vassalli F, Naeije R, Brimioulle S.

Am J Physiol Heart Circ Physiol. 2004 Apr;286(4):H1441-7. Epub 2003 Dec 18.

PMID:
14684368
5.

Bosentan treatment is associated with improvement of right ventricular function and remodeling in chronic thromboembolic pulmonary hypertension.

Surie S, Reesink HJ, Marcus JT, van der Plas MN, Kloek JJ, Vonk-Noordegraaf A, Bresser P.

Clin Cardiol. 2013 Nov;36(11):698-703. doi: 10.1002/clc.22197. Epub 2013 Aug 27.

6.

Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension.

Gavazzi A, Ghio S, Scelsi L, Campana C, Klersy C, Serio A, Raineri C, Tavazzi L.

Am Heart J. 2003 Feb;145(2):310-6.

PMID:
12595849
7.

Right ventricular pressure waveform and wave reflection analysis in patients with pulmonary arterial hypertension.

Karamanoglu M, McGoon M, Frantz RP, Benza RL, Bourge RC, Barst RJ, Kjellström B, Bennett TD.

Chest. 2007 Jul;132(1):37-43. Epub 2007 May 15.

PMID:
17505045
8.

Functional and metabolic recovery of the right ventricle during Bosentan therapy in idiopathic pulmonary arterial hypertension.

Spindler M, Schmidt M, Geier O, Sandstede J, Hahn D, Ertl G, Beer M.

J Cardiovasc Magn Reson. 2005;7(5):853-4.

PMID:
16353449
9.

Combination therapy in pulmonary arterial hypertension: do we have the right strategy?

Mukherjee B, Howard L.

Expert Rev Respir Med. 2011 Apr;5(2):191-205. doi: 10.1586/ers.11.13. Review.

PMID:
21510730
10.

Inhaled nitric oxide for pulmonary hypertension after heart transplantation.

Ardehali A, Hughes K, Sadeghi A, Esmailian F, Marelli D, Moriguchi J, Hamilton MA, Kobashigawa J, Laks H.

Transplantation. 2001 Aug 27;72(4):638-41.

PMID:
11544423
11.

Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol.

Oikawa M, Kagaya Y, Otani H, Sakuma M, Demachi J, Suzuki J, Takahashi T, Nawata J, Ido T, Watanabe J, Shirato K.

J Am Coll Cardiol. 2005 Jun 7;45(11):1849-55.

12.

Sample size and cost analysis for pulmonary arterial hypertension drug trials using various imaging modalities to assess right ventricular size and function end points.

Addetia K, Bhave NM, Tabit CE, Gomberg-Maitland M, Freed BH, Dill KE, Lang RM, Mor-Avi V, Patel AR.

Circ Cardiovasc Imaging. 2014 Jan;7(1):115-24. doi: 10.1161/CIRCIMAGING.113.000932. Epub 2013 Nov 5.

13.

Changes in right ventricular structure and function assessed using cardiac magnetic resonance imaging in bosentan-treated patients with pulmonary arterial hypertension.

Chin KM, Kingman M, de Lemos JA, Warner JJ, Reimold S, Peshock R, Torres F.

Am J Cardiol. 2008 Jun 1;101(11):1669-72. doi: 10.1016/j.amjcard.2008.01.055. Epub 2008 Apr 18.

PMID:
18489949
14.

[Sildenafil improves right ventricular function in a cardiac transplant recipient].

Paez RP, Araujo WF, Hossne NA Jr, Neves AL, Vargas GF, Aguiar Lde F, Branco JN, Catani R, Buffolo E.

Arq Bras Cardiol. 2005 Feb;84(2):176-8. Epub 2005 Mar 8. Portuguese.

15.

Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension.

Tedford RJ, Mudd JO, Girgis RE, Mathai SC, Zaiman AL, Housten-Harris T, Boyce D, Kelemen BW, Bacher AC, Shah AA, Hummers LK, Wigley FM, Russell SD, Saggar R, Saggar R, Maughan WL, Hassoun PM, Kass DA.

Circ Heart Fail. 2013 Sep 1;6(5):953-63.

16.

Pulmonary hypertension and right ventricular function in advanced heart failure.

Kalogeropoulos AP, Vega JD, Smith AL, Georgiopoulou VV.

Congest Heart Fail. 2011 Jul-Aug;17(4):189-98. doi: 10.1111/j.1751-7133.2011.00234.x. Epub 2011 Jul 21. Review.

17.

Pulmonary hypertension, right ventricular function, and clinical outcome in acute decompensated heart failure.

Aronson D, Darawsha W, Atamna A, Kaplan M, Makhoul BF, Mutlak D, Lessick J, Carasso S, Reisner S, Agmon Y, Dragu R, Azzam ZS.

J Card Fail. 2013 Oct;19(10):665-71. doi: 10.1016/j.cardfail.2013.08.007.

PMID:
24125104
18.

Prostanoids but not oral therapies improve right ventricular function in pulmonary arterial hypertension.

Brittain EL, Pugh ME, Wheeler LA, Robbins IM, Loyd JE, Newman JH, Austin ED, Hemnes AR.

JACC Heart Fail. 2013 Aug;1(4):300-307. doi: 10.1016/j.jchf.2013.05.004.

19.

Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy.

van de Veerdonk MC, Kind T, Marcus JT, Mauritz GJ, Heymans MW, Bogaard HJ, Boonstra A, Marques KM, Westerhof N, Vonk-Noordegraaf A.

J Am Coll Cardiol. 2011 Dec 6;58(24):2511-9. doi: 10.1016/j.jacc.2011.06.068.

20.

Selective reduction of afterload in right heart assist therapy: a mock loop study†.

Hsu PL, Hatam N, Unterkofler J, Goetzenich A, McIntyre M, Wong KC, Egger C, Schmitz-Rode T, Autschbach R, Steinseifer U.

Interact Cardiovasc Thorac Surg. 2014 Jul;19(1):76-81. doi: 10.1093/icvts/ivu067. Epub 2014 Mar 26.

PMID:
24670773

Supplemental Content

Support Center